These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 21083243)
21. Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC). Boterman M; Doig M; Breda M; Lowes S; Jersey J; Shoup R; Garofolo F; Dumont I; Martinez S; Needham S; Cruz Caturla M; Couerbe P; Guittard J; Maltas J; Lansing T; Bhatti M; Schiebl C; Struwe P; Sheldon C; Hayes R; Sangster T; Pattison C; Bouchard J; Goodwin L; Islam R; Segers R; Lin ZJ; Hillier J; Garofolo W; Zimmer D; Folguera L; Zimmermann T; Pawula M; Moussallie M; Teixeira Lde S; Rocha T; Tang D; Jardieu P; Truog J; Lin J; Lundberg R; Cox C; Breau A; Bigogno C; Schoutsen D; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Nicholson R; Jenkins R; Lin MH; Karnik S; De Boer T; Houghton R; Green R; DeMaio W; Sable R; Smith K; Siethoff C; Cojocaru L; Allen M; Harter T; Fatmi S; Sayyarpour F; Malone M; Best S; Fang X Bioanalysis; 2012 Mar; 4(6):651-60. PubMed ID: 22452256 [No Abstract] [Full Text] [Related]
22. Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry. Kadian N; Raju KS; Rashid M; Malik MY; Taneja I; Wahajuddin M J Pharm Biomed Anal; 2016 Jul; 126():83-97. PubMed ID: 27179186 [TBL] [Abstract][Full Text] [Related]
23. A new approach to evaluate regression models during validation of bioanalytical assays. Singtoroj T; Tarning J; Annerberg A; Ashton M; Bergqvist Y; White NJ; Lindegardh N; Day NP J Pharm Biomed Anal; 2006 Apr; 41(1):219-27. PubMed ID: 16332425 [TBL] [Abstract][Full Text] [Related]
24. Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods. Zacharis CK; Tzanavaras PD J Pharm Biomed Anal; 2008 Nov; 48(3):483-96. PubMed ID: 18599247 [TBL] [Abstract][Full Text] [Related]
25. International harmonization of bioanalytical guidance. Bansal SK; Arnold M; Garofolo F Bioanalysis; 2010 Apr; 2(4):685-7. PubMed ID: 21083262 [No Abstract] [Full Text] [Related]
26. [Criteria for management and use of instrumental techniques]. Crea AE Ann Ist Super Sanita; 2002; 38(1):53-5. PubMed ID: 12122895 [TBL] [Abstract][Full Text] [Related]
27. Quality control and analytical techniques for biopharmaceuticals. Robinson CJ; Jones C Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369 [TBL] [Abstract][Full Text] [Related]
28. Incurred sample reanalysis: a global transformation. Viswanathan CT Bioanalysis; 2011 Dec; 3(23):2601-2. PubMed ID: 22136048 [TBL] [Abstract][Full Text] [Related]
29. Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective. Raman NV; Prasad AV; Ratnakar Reddy K J Pharm Biomed Anal; 2011 Jun; 55(4):662-7. PubMed ID: 21193280 [TBL] [Abstract][Full Text] [Related]
30. Accuracy and precision for analytical results. Hajian G J Biopharm Stat; 1994 Mar; 4(1):31-7. PubMed ID: 8019582 [TBL] [Abstract][Full Text] [Related]
31. Bioanalysis and Analytical Services Research Group at The Municipal Institute for Medical Research IMIM-Hospital del Mar, Spain. Segura J; Pascual JA; Ventura R; Gutiérrez-Gallego R Bioanalysis; 2009 Nov; 1(8):1403-9. PubMed ID: 21083089 [TBL] [Abstract][Full Text] [Related]
32. EBF recommendation on the validation of bioanalytical methods for dried blood spots. Timmerman P; White S; Globig S; Lüdtke S; Brunet L; Smeraglia J Bioanalysis; 2011 Jul; 3(14):1567-75. PubMed ID: 21749218 [TBL] [Abstract][Full Text] [Related]
33. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010). Schepers U; Wätzig H J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114 [TBL] [Abstract][Full Text] [Related]
34. Capsule review on bioanalytical method transfer: opportunities and challenges for chromatographic methods. Lin ZJ; Li W; Weng N Bioanalysis; 2011 Jan; 3(1):57-66. PubMed ID: 21175367 [TBL] [Abstract][Full Text] [Related]
35. Conducting remote bioanalytical data monitoring and review based on scientific quality objectives. He L Bioanalysis; 2011 Jul; 3(13):1447-56. PubMed ID: 21728770 [TBL] [Abstract][Full Text] [Related]
36. Development, validation and transfer of a near infrared method to determine in-line the end point of a fluidised drying process for commercial production batches of an approved oral solid dose pharmaceutical product. Peinado A; Hammond J; Scott A J Pharm Biomed Anal; 2011 Jan; 54(1):13-20. PubMed ID: 20801599 [TBL] [Abstract][Full Text] [Related]
37. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment. Roller ST; Pippins RR; Ngai JW Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646 [TBL] [Abstract][Full Text] [Related]
38. Incurred sample reanalysis: dilemma in its applicability - should it be practiced for all bioanalytical assays involving single (parent or metabolite) or multiple analytes (parent/metabolite or parent with co-administered drugs)? Srinivas NR Biomed Chromatogr; 2011 Jun; 25(6):737-9. PubMed ID: 21465501 [No Abstract] [Full Text] [Related]
39. Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics. Lee JW Bioanalysis; 2009 Nov; 1(8):1461-74. PubMed ID: 21083095 [TBL] [Abstract][Full Text] [Related]
40. Bioanalytical method requirements and statistical considerations in incurred sample reanalysis for macromolecules. Thway TM; Macaraeg CR; Calamba D; Brunner LA; Eschenberg M; Pourvasei R; Zhang L; Ma M; Desilva B Bioanalysis; 2010 Sep; 2(9):1587-96. PubMed ID: 21083287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]